SERGIO HAYNES: Open Payments
NPI 1528391901 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,602 in 110 payments from 17 companies in 2025. Trend: 2023 $2,056 · 2024 $2,029 · 2025 $1,602
Food & beverage: $1,602
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $240 |
| AstraZeneca Pharmaceuticals LP | 8 | $206 |
| PFIZER INC. | 17 | $201 |
| Novo Nordisk Inc | 15 | $200 |
| Lilly USA, LLC | 9 | $161 |
| GlaxoSmithKline, LLC. | 13 | $161 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85 |
| Abbott Laboratories | 4 | $69 |
| Biogen, Inc. | 3 | $63 |
| Astellas Pharma US Inc | 3 | $56 |
Products named: NURTEC ODT, JARDIANCE, AIRSUPRA, TRELEGY ELLIPTA, MOUNJARO, QULIPTA, VRAYLAR, FARXIGA.
Industry payments across TX — which companies pay providers there.
